Carrie Jones, ND, MPH - LDN and Cellular Hypothyroidism: Why you can't convert T4 into T3 (2019 Conference) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr. Brian Udell, Low Dose Naltrexone - Key Ingredient in the biomedical treatment of Autism Spectrum Disorder.

Learn about autism, the epidemic, and how LDN fits into a comprehensive therapeutic protocol to allow healing to take place. 

Elizabeth Livengood, NMD - LDN and MDD: A Case Study - Treating Depression in Patients with Autoimmune Conditions (2019 Conference) (LDN, low dose naltrexone)

Armin Schwarzbach, PhD, MD - Infections in Cancer and Autoimmune Disorders II (2019 Conference) (LDN, low dose naltrexone)

Yoon Hang "John" Kim, MD - Treating chronic pain with low dose naltrexone and ultra low dose naltrexone (2019 Conference) (LDN, low dose naltrexone)

Ted Cole, DO - The Use of LDN and Amino Acids in Parkinson's Disease (2019 Conference) (LDN, low dose naltrexone)

Tara Thompson, PharmD - Compounding 101: The Basics of Compounding with Naltrexone (2019 Conference) (LDN, low dose naltrexone)

Tara Thompson, PharmD discusses the purpose of a compounding pharmacy, how to choose one, the benefits and limitations of compounding, and dosage forms. She give an overview of naltrexone, dosing of LDN in various conditions, and how to write a prescription for compounded naltrexone.

Stephen Dickson, BSC (hons) MRPharmS - Mechanism of Action of Low Dose Naltrexone (2019 Conference) (LDN, low dose naltrexone)

Scott Zashin, MD - Treatment of Sjogren's Syndrome with LDN (2019 Conference) (LDN, low dose naltrexone)

Sarah Zielsdorf, MD, MS - Graves' Disease (2019 Conference) (LDN, low dose naltrexone)

Sarah Zielsdorf, MD discusses what Graves’ disease is, treatment strategies, related conditions and predisposing factors, and the work-up from a functional medicine standpoint